Immunomodulation by the new synthetic compound BM 12.531,2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone)
- 1 January 1981
- journal article
- research article
- Published by Elsevier in Experimental pathology
- Vol. 19 (1) , 37-48
- https://doi.org/10.1016/s0232-1513(81)80053-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531Cellular and Molecular Life Sciences, 1979
- IN VITRO STUDIES ON NORMAL, STIMULATED AND IMMUNOLOGICALLY ACTIVATED MOUSE MACROPHAGESActa Pathologica Microbiologica Scandinavica Section C Immunology, 1977
- Mechanism of lymphocyte activation: the binding of phytohemagglutinin to the lymphocyte surfaceEuropean Journal of Immunology, 1977
- Suppression of Lymphoproliferation by High Concentrations of Normal Human Mononuclear LeukocytesThe Journal of Immunology, 1977
- POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY FORMATION WITH CYCLOPHOSPHAMIDEThe Journal of Experimental Medicine, 1974
- INFLUENCE OF DOSE AND ROUTE OF ANTIGEN INJECTION ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- Cell propagation on films of polymeric fluorocarbon as a means to regulate pericellular pH and pO2 in cultured monolayersFEBS Letters, 1971
- Plaque Formation in Agar by Single Antibody-Producing CellsScience, 1963